Pharmaceutical Investors

Investors

Investor relations at Salix

At Salix, we create value for our investors by developing & marketing innovative products that help diagnose or treat gastrointestinal disorders. Please browse this section to learn more about our financial performance.

Download our financial reports

Access financial presentations

Download our corporate presentation

If you do not find what you are looking for in this section, or if you require additional assistance, please contact:
G. Michael Freeman
Associate Vice President, Investor Relations & Corporate Communications
Phone: 919-862-1000
Email: investor.relations@salix.com

SWB10-0814




Explore Career Opportunities with Salix
Check out our latest Press Releases and News